Medical specialists from Japan tagged as investigators in clinical trials studying Diffuse Cutaneous Systemic Sclerosis
Total 15 results
-
Atsushi Kawakami, MDSeen in:
- Nagasaki, Nagasaki-Shi, Nagasaki University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Futoshi IwataSeen in:
- Tokyo, St. Luke's International Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Hidekata Yasuoka, BCh, MD, PhDSeen in:
- Aiti, Toyoake-shi, Fujita Health University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Hiroaki Niiro, MDSeen in:
- Fukuoka, Kyushu University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Hiroki Takahashi, MD, PhDSeen in:
- Hokkaidô, Sapporo-Shi, Sapporo Medical University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Masakazu Matsushita, MDSeen in:
- Tokyo, Bunkyo-Ku, Juntendo University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Masaru KatoSeen in:
- Hokkaido, GSK Investigational Site
- Hokkaidô, Sapporo-Shi, Hokkaido University Hospital
- Sapporo-shi, Hokkaido University Hospital - Dept of Internal Medicine 2(Rheumatology/Immunolog
Trials:- NCT04781543 (Principal Investigator)
- NCT05162586 (Principal Investigator)
- NCT05878717 (Principal Investigator)
-
Masataka Kuwana, MD, PhDSeen in:
- Tokyo, Nippon Medical School Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Shinya Hirata, MDSeen in:
- Kumamoto, Kumamoto-Shi, Kumamoto University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Sumiaki Tanaka, MDSeen in:
- Saitama, Kitamoto-Shi, Kitasato University Medical Center
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Tohru Takeuchi, MDSeen in:
- Ôsaka, Takatsuki-Shi, Osaka Medical and Pharmaceutical University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Tomonori IshiiSeen in:
- Miyagi, GSK Investigational Site
- Miyagi, Sendai-shi, Tohoku University Hospital
- Sendai-shi, Tohoku University Hospital - Dept of Hematology/Immunology
Trials:- NCT05540327 (Principal Investigator)
- NCT04781543 (Principal Investigator)
- NCT05162586 (Principal Investigator)
- NCT05878717 (Principal Investigator)
-
Toshihide Mimura, MD, PhDSeen in:
- Saitama, Iruma-Gun, Saitama Medical University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Yasushi Kawaguchi, MDSeen in:
- Tokyo, Shinjuku-ku, Tokyo Women's Medical University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Yoshihito Shima, MDSeen in:
- Ôsaka, Suita-Shi, Osaka University Hospital
Trials:- NCT04781543 (Principal Investigator)
Conditions:
Clinical Trials on Diffuse Cutaneous Systemic Sclerosis
-
University of ManchesterCompletedEarly Diffuse Cutaneous Systemic Sclerosis
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
AmgenEnrolling by invitationDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicKorea, Republic of, France, United States, Spain, Mexico, Japan, Argentina, Greece, Israel
-
AmgenRecruitingDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicUnited States, Korea, Republic of, Germany, Spain, Italy, Israel, Japan, Serbia, Argentina, Greece, Mexico, Poland, Chile, Austria, France, Portugal, Romania, Switzerland, United Kingdom
-
Lawson Health Research InstituteMallinckrodtNot yet recruitingDiffuse Cutaneous Systemic SclerosisCanada
-
Mitsubishi Tanabe Pharma America Inc.CompletedDiffuse Cutaneous Systemic SclerosisSpain, Belgium, United States, United Kingdom, Poland, Canada, Germany, Italy
-
CSL BehringCompletedDiffuse Cutaneous Systemic SclerosisAustralia, Germany, Poland, Italy, United Kingdom
-
Hospital for Special Surgery, New YorkHuman Genome Sciences Inc.CompletedSystemic SclerosisUnited States
-
CSL BehringWithdrawnDiffuse Cutaneous Systemic SclerosisBelgium, United States, Italy, Spain, France, Germany, United Kingdom, Argentina, Australia, Canada, Mexico, Poland, Switzerland
-
Dinesh Khanna, MD, MSBristol-Myers Squibb; National Institute of Allergy and Infectious Diseases...CompletedDiffuse Cutaneous Systemic SclerosisUnited States, Canada, United Kingdom